0 31/03/2022 2022-03-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2021-04-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12200885 2021-04-01 2022-03-31 12200885 2022-03-31 12200885 2021-03-31 12200885 bus:RegisteredOffice 2021-04-01 2022-03-31 12200885 bus:LeadAgentIfApplicable 2021-04-01 2022-03-31 12200885 bus:Director1 2021-04-01 2022-03-31 12200885 bus:Director2 2021-04-01 2022-03-31 12200885 bus:Director3 2021-04-01 2022-03-31 12200885 core:WithinOneYear 2022-03-31 12200885 core:WithinOneYear 2021-03-31 12200885 core:AfterOneYear 2022-03-31 12200885 core:AfterOneYear 2021-03-31 12200885 core:ShareCapital 2022-03-31 12200885 core:ShareCapital 2021-03-31 12200885 core:RetainedEarningsAccumulatedLosses 2022-03-31 12200885 core:RetainedEarningsAccumulatedLosses 2021-03-31 12200885 bus:SmallEntities 2021-04-01 2022-03-31 12200885 bus:AuditExempt-NoAccountantsReport 2021-04-01 2022-03-31 12200885 bus:FullAccounts 2021-04-01 2022-03-31 12200885 bus:SmallCompaniesRegimeForAccounts 2021-04-01 2022-03-31 12200885 bus:PrivateLimitedCompanyLtd 2021-04-01 2022-03-31 12200885 1 2021-04-01 2022-03-31 12200885 core:AllAssociates 2021-04-01 2022-03-31
Company registration number: 12200885
Neuromed Limited
Unaudited filleted financial statements
31 March 2022
Neuromed Limited
Contents
Directors and other information
Statement of financial position
Notes to the financial statements
Neuromed Limited
Directors and other information
Directors Mr M Shaw
Mr M McCarty
Dr J Briffa
Company number 12200885
Registered office The Genesis Centre
Innovation Way
Stoke on Trent
Staffordshire
ST6 4BF
Business address The Genesis Centre
Innovation Way
Stoke on Trent
Staffordshire
ST6 4BF
Accountants Jacksons
Chartered Accountants
Deansfield House
98 Lancaster Road
Newcastle under Lyme
Staffordshire
ST5 1DS
Neuromed Limited
Statement of financial position
31 March 2022
2022 2021
Note £ £ £ £
Current assets
Stocks 16,744 14,813
Debtors 5 3,978 2,850
Cash at bank and in hand 20,540 9,081
_______ _______
41,262 26,744
Creditors: amounts falling due
within one year 6 ( 11,350) ( 6,296)
_______ _______
Net current assets 29,912 20,448
_______ _______
Total assets less current liabilities 29,912 20,448
Creditors: amounts falling due
after more than one year 7 ( 14,997) ( 14,997)
_______ _______
Net assets 14,915 5,451
_______ _______
Capital and reserves
Called up share capital 3 3
Profit and loss account 14,912 5,448
_______ _______
Shareholders funds 14,915 5,451
_______ _______
For the year ending 31 March 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 12 August 2022 , and are signed on behalf of the board by:
Mr M Shaw
Director
Company registration number: 12200885
Neuromed Limited
Notes to the financial statements
Year ended 31 March 2022
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Neuromed Limited, The Genesis Centre, Innovation Way, Stoke on Trent, Staffordshire, ST6 4BF.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stocks to their present location and condition.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.Debt instruments are subsequently measured at amortised cost.
4. Employee numbers
The average number of persons employed by the company during the year amounted to Nil (2021: Nil).
5. Debtors
2022 2021
£ £
Trade debtors 3,852 2,648
Other debtors 126 202
_______ _______
3,978 2,850
_______ _______
6. Creditors: amounts falling due within one year
2022 2021
£ £
Trade creditors 8,580 4,447
Corporation tax 2,220 1,349
Other creditors 550 500
_______ _______
11,350 6,296
_______ _______
7. Creditors: amounts falling due after more than one year
2022 2021
£ £
Other creditors 14,997 14,997
_______ _______
8. Events after the end of the reporting period
The directors have considered the impact of the COVID-19 crisis on the business operations and the impact on the financial performance of the company.The directors believe that the company is well placed to manage its business risks despite theuncertain economic outlook.
9. Related party transactions
Mr M Shaw , Mr M McCarty and Dr J Briffa are related parties by virtue or their directorship of and shareholding in the company . Mr M Shaw has provided the company with an interest free loan such that at the year end the company owed the sum of £4,999 (2021 : £4,999).Mr M McCarty has provided the company with an interest free loan such that at the year end the company owed the sum of £4,999 (2021 : £4,999).Dr J Briffa has provided the company with an interest free loan such that at the year end the company owed the sum of £4,999 (2021 : £4,999).During the year, Neuromed Limited made sales to WFBM Healthcare Limited, a company in which Mr M Shaw and Mr M McCarty are also directors, during the year totalling £27,958 (2021 : £27,136).
10. Controlling party
No one party controls the company.